// App-Quantinova.ai

E097 : The efficacy and tolerability of secukinumab in psoriatic arthritis and ankylosing spondylitis in NHS Tayside

Researchers

Presenter

  • Sam Cooper

Principal Investigators

  • Smita Bhat

Medical Centers

  • Medical student, Ninewells Hospital and Medical School, Dundee, UNITED KINGDOM

  • Consultant Rheumatologist, Ninewells Hospital and Medical School, Dundee, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ankylosing spondylitis

  • Psoriatic arthritis

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • secukinumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved